Severe Telaprevir Rashes and Waiting (or Not Waiting) to Treat Hepatitis C

Should ID doctors treat patients with HCV now, or wait until treatment options improve? Take our poll at HIV and ID Observations.

The FDA recently issued a drug safety alert about potentially fatal rashes in patients treated for hepatitis C virus infection with interferon, ribavirin, and telaprevir. In his blog HIV and ID Observations, Dr. Paul Sax questions whether patients with HCV should be treated now rather than waiting for safer and more-effective regimens. What do you think? Take our poll here.

Severe Telaprevir Rashes and Waiting (or Not Waiting) to Treat Hepatitis C

Topics